Details of the Drug Formulations

General Information of Drug (ID: DM1P6FR)

Drug Name
Arry-162 Drug Info
Synonyms
606143-89-9; Binimetinib; MEK162; MEK-162; ARRY-438162; 5-[(4-Bromo-2-fluorophenyl)amino]-4-fluoro-N-(2-hydroxyethoxy)-1-methyl-1H-benzimidazole-6-carboxamide; ARRY 162; UNII-181R97MR71; Binimetinib (MEK162, ARRY-162, ARRY-438162); 181R97MR71; MEK162 (ARRY-162, ARRY-438162); 6-(4-bromo-2-fluorophenylamino)-7-fluoro-N-(2-hydroxyethoxy)-3-methyl-3H-benzo[d]imidazole-5-carboxamide; Binimetinib [USAN:INN]; MEK 162; ARRY 438162; MEK162(Binimetinib); Binimetinib (JAN/USAN); D0C4LF; NVP-ME
Indication
Disease Entry ICD 11 Status REF
Melanoma 2C30 Approved [1]
Cross-matching ID
PubChem CID
10288191
ChEBI ID
CHEBI:145371
CAS Number
606143-89-9
TTD ID
D0C4LF
VARIDT ID
DR01336
INTEDE ID
DR0214
ACDINA ID
D00883

Full List of Drug Formulations Containing This Drug

Binimetinib 15 mg tablet
Company Formulation ID FDA Description
Array Biopharma F23088 Lactose Monohydrate; Microcrystalline Cellulose; Croscarmellose Sodium; Magnesium Stearate (Vegetable Source); Colloidal Silicon Dioxide; Polyvinyl Alcohol; Polyethylene Glycol; Titanium Dioxide; Talc; Ferric Oxide Yellow; Ferrosoferric Oxide
------------------------------------------------------------------------------------

References

1 2018 FDA drug approvals.Nat Rev Drug Discov. 2019 Feb;18(2):85-89.